Company

Company Outline

  • Company Name
    Novacellum,inc
  • Established
    December 2019
  • Capital
    5,500,000 yen
  • Members
    Chairman; Naohide Yamashita (Professor Emeritus, The University of Tokyo, Doctor of Medicine)
    Representative; Director Masaki Ohara
  • Location
    7F, Sagamiya Headquarters Building, 6 Ichibancho, Chiyoda-ku, Tokyo 102-0082
  • Business
    Research on diseases using genes and gene products, cells, and tissues, development of therapeutic methods, and sales of the results, etc.

Access

7F, Sagamiya Headquarters Building, 6 Ichibancho, Chiyoda-ku, Tokyo 

3 minutes walk from Exit 5 of Hanzomon Station on the Hanzomon Subway Line

large map

Message

Nova Serum Co., Ltd. aims to develop new treatments to meet the needs of society. Since the clinical application of immune checkpoint inhibitors, immunotherapy for cancer has received a great deal of attention. However, only some patients are effective, and further progress in cancer immunotherapy is desired. In addition, the development of personalized medicine using genomic information is remarkable, and neoantigen immunotherapy by fusion with cancer immunotherapy is also being performed.

We are committed to developing new therapies for our patients. Chairman Naohide Yamashita

Chairman Naohide Yamashita

Chairman Naohide Yamashita
Professor Emeritus, University of Tokyo, Doctor of Medicine

  • 1977
    Graduated from the University of Tokyo School of Medicine in 1977
  • 2001-2016
    Professor, Institute of Medical Science, University of Tokyo
  • 2006-2010
    Director, Institute of Medical Science, University of Tokyo
  • 2019-
    Present Chairman of Novacellum inc.

Representative Director Masaki Ohara

  • 1991-1994
    Cannon Co., Ltd.
  • 1994-2013
    Hitachi Brain Co., Ltd.
  • 2013
    Hitachi Building Systems Techno Service Co., Ltd.
  • 2013-2015
    Sentan Inc.
  • 2015
    Established Radix Co., Ltd
  • 2018
    Established INFER Co., Ltd.
  • 2019
    Established Novacellum inc.